Cochrane · systematic review · CD011399

Antibiotic therapy for adults with neurosyphilis

Buitrago‐Garcia, D, Martí‐Carvajal, AJ, Jimenez, A, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Sexually Transmitted InfectionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
4
No studies
3
Included studies
NR
No studies 3 · 42.9%Ungraded 0 · 0%Very low 4 · 57.1%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Ceftriaxone compared to penicillin G for neurosyphilis

Population: people with neurosyphilis
7 questions
OutcomeEffectEvidenceStatus / GRADE
Serological cure assessed by decrease in the CSF VDRL titre
Ceftriaxone vs penicillin G
no estimate extracted1 study · 36 participantsVery low
Downgraded: risk of bias, imprecision
Clinical cure assessed by RPR decrease
Ceftriaxone vs penicillin G
no estimate extracted1 study · 36 participantsVery low
Downgraded: risk of bias, imprecision
Adverse events Any untoward medical occurrence regarding medications
Ceftriaxone vs penicillin G
no estimate extracted1 study · 1 participantsVery low
Downgraded: risk of bias, imprecision
Recurrence of neurosyphilis
Ceftriaxone vs penicillin G
no estimate extractedNRNo studies
Time to recovery
Ceftriaxone vs penicillin G
no estimate extractedNRNo studies
Quality of life
Ceftriaxone vs penicillin G
no estimate extractedNRNo studies
Withdrawals
Ceftriaxone vs penicillin G
RR 2 [0.42, 9.48]1 study · 36 participantsVery low
Downgraded: risk of bias, imprecision